Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Thyroid Disease and Systemic Lupus Erythematosus

Version 1 : Received: 4 October 2023 / Approved: 6 October 2023 / Online: 6 October 2023 (12:29:21 CEST)

A peer-reviewed article of this Preprint also exists.

Athanassiou, L.; Kostoglou-Athanassiou, I.; Kaiafa, G.; Tsakiridis, P.; Koukosias, N.; Mitsoulis, S.; Savopoulos, C.; Athanassiou, P. Thyroid Disease and Systemic Lupus Erythematosus. Medicina 2023, 59, 1911. Athanassiou, L.; Kostoglou-Athanassiou, I.; Kaiafa, G.; Tsakiridis, P.; Koukosias, N.; Mitsoulis, S.; Savopoulos, C.; Athanassiou, P. Thyroid Disease and Systemic Lupus Erythematosus. Medicina 2023, 59, 1911.

Abstract

Background and Objectives: Thyroid disease has been associated with autoimmune disorders. As systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse manifestations spanning across all organ systems, the relationship of SLE with thyroid disorders needs investigation. In particular, the relationship of SLE with autoimmune thyroid disease has attracted the interest of the research community. The aim was to evaluate the relationship of SLE with autoimmune thyroid disease. Materials and Methods: A cohort of 45 consecutive patients, mean age 47,97 years (range 21-79 years) and 45 age and sex-matched controls were prospectively studied over a period of 12 months for the presence of thyroid disease and the prevalence of antithyroid antibodies. Results: Four patients (8.9%) were found to suffer from primary hypothyroidism, 5 (11.11%) from subclinical hypothyroidism and 1 (2.22%) from hyperthyroidism, whereas 1 (2.22%) of the controls had primary hypothyroidism and 1 (2.22%) had hyperthyroidism. Five patients (11.11%) had a thyroid hormone profile compatible with the presence of euthyroid sick syndrome. Thyroid peroxidase (TPOab) and thyroglobulin (Tgab) antibodies were detected in 20/45 and 15/45 of the SLE population and in 7/45 and 5/45 of the controls, respectively (p<0.05, chi square test). Conclusions: In conclusion, the incidence of clinical thyroid disease is greater amongst SLE patients than in a control population and in a significant number of these patients antithyroid antibodies are detectable. Thus, a subset of lupus patients appears to be predisposed to the development of thyroid disease and this should be considered when evaluating patients with SLE.

Keywords

systemic lupus erythematosus; autoimmune thyroid disease; hypothyroidism; hyperthyroidism; thyroid peroxidase antibodies; thyroglobulin antibodies

Subject

Medicine and Pharmacology, Endocrinology and Metabolism

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.